Bogdan Mitran Selected Research

1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononane

12/2020	Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer.
11/2019	Increase in negative charge of 68Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules.
1/2018	Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model.
5/2016	Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bogdan Mitran Research Topics

Disease

41	Neoplasms (Cancer) 05/2024 - 07/2014
11	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 05/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2019 - 11/2016
1	Disease Progression 11/2023
1	Arthritis (Polyarthritis) 11/2023
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Glioma (Gliomas) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Idiopathic Pulmonary Fibrosis 12/2016
1	Squamous Cell Carcinoma of Head and Neck 04/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2016

Drug/Important Bio-Agent (IBA)

23	Radioisotopes (Radionuclides)IBA 01/2020 - 07/2014
12	Bombesin Receptors (Bombesin Receptor)IBA 12/2020 - 07/2014
9	ErbB Receptors (EGF Receptor)IBA 11/2019 - 10/2015
8	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 11/2023 - 01/2016
8	Chelating AgentsIBA 03/2020 - 01/2016
5	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 12/2020 - 07/2014
5	BombesinIBA 01/2020 - 07/2014
5	Proteins (Proteins, Gene)FDA Link 10/2018 - 11/2016
4	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 12/2020 - 05/2016
3	AntigensIBA 07/2020 - 07/2019
3	Trastuzumab (Herceptin)FDA Link 12/2019 - 01/2018
3	Epidermal Growth Factor (EGF)IBA 01/2019 - 11/2017
3	Tyrosine Kinase InhibitorsIBA 01/2018 - 04/2016
3	Cys-ZHER2-342 affibodyIBA 01/2018 - 11/2017
2	EnzymesIBA 01/2020 - 11/2016
2	CobaltIBA 11/2019 - 01/2017
2	Carbonic Anhydrase IXIBA 10/2019 - 11/2016
2	Designed Ankyrin Repeat ProteinsIBA 01/2019 - 01/2018
2	human ERBB2 proteinIBA 01/2018 - 01/2018
2	AntibodiesIBA 01/2018 - 12/2016
2	Peptide Nucleic AcidsIBA 01/2018 - 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023
1	Cobalt-55IBA 12/2020
1	Copper-64IBA 12/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	phosphoramidonIBA 12/2019
1	Pentetic Acid (DTPA)FDA LinkGeneric 10/2019
1	Immunoglobulin FragmentsIBA 10/2019
1	Hormones (Hormone)IBA 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	Maytansine (Maitansine)IBA 10/2018
1	AlbuminsIBA 01/2018
1	Ado-Trastuzumab EmtansineIBA 01/2018
1	Lapatinib (GW572016)FDA Link 01/2018
1	Technetium (Technetium 99m)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	pertuzumabIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2017
1	Indium-111IBA 11/2017
1	indium- 111- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetraacetic acidIBA 11/2017
1	Peptides (Polypeptides)IBA 12/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2016
1	compound 21IBA 12/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2016
1	Monoclonal AntibodiesIBA 04/2016
1	Insulin (Novolin)FDA Link 02/2015
1	Peptide Receptors (Peptide Receptor)IBA 07/2014

Therapy/Procedure

25	Therapeutics 12/2019 - 07/2014
1	Radiotherapy 12/2019
1	Precision Medicine 07/2019